Sigma Planning’s Cytokinetics CYTK Stock Holding History
Bought
Maintained
Sold
Other funds holding CYTK
Sigma Planning's CYTK Position: Q3 2026 in Review
Sigma Planning sold out of Cytokinetics (CYTK) in Q3 2026, closing a stake of 2,724 shares — an estimated $232K sold.
Sigma Planning first reported a position in CYTK in Q2 2020 and held it in 2 quarters. The position peaked at $232K in Q2 2026. 348 funds tracked by Wall St. Rank hold CYTK as of Q3 2026.
- Sigma Planning reported no remaining Cytokinetics position as of Q3 2026 after selling out during the quarter.
- Sigma Planning sold 2,724 Cytokinetics shares in Q3 2026, an estimated $232K.
- Sigma Planning first reported a position in Cytokinetics in Q2 2020 and held it in 2 quarters.
- Sigma Planning's Cytokinetics position peaked at $232K in Q2 2026.
- 348 funds tracked by Wall St. Rank held Cytokinetics as of Q3 2026.
Based on Sigma Planning's 13F filing for Q3 2026, filed 23 Oct 2026.